文献速递妇科

老年共病管理使晚期卵巢癌老年女性在三级癌症中心安全接受肿瘤细胞减灭术

Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center.
PubMed 文献 · Gynecol Oncol · 2019-05-08

本研究前瞻性纳入42例接受肿瘤细胞减灭术的晚期卵巢癌老年女性,术前由老年医学科评估并术后共管。结果显示最佳减灭率97%、完全肉眼切除率63%,30天ICU入住1例、急诊就诊26%、再入院10%,无180天死亡。作者认为在三级中心通过老年与外科共管可安全实施手术。

要点

  • 42例晚期卵巢癌老年女性(中位年龄79岁)接受肿瘤细胞减灭术,最佳减灭率97%。
  • 术后30天急诊就诊率26%、再入院率10%,仅1例入住ICU,无180天死亡。
  • 作者认为在三级中心通过术前术后老年与外科共管可安全实施手术。

核心结论

  • 作者认为,患有晚期卵巢癌且衰弱的老年女性可在三级医疗中心通过术前和术后老年医学与外科共管安全地接受肿瘤细胞减灭术。

研究设计与样本

  • 前瞻性研究,纳入转诊至老年医学门诊进行术前评估的卵巢癌患者,所有患者完成电子快速体能评估(eRFA),术后住院期间由老年医学服务随访并与外科服务共管。
  • 共42例女性(中位年龄79岁,范围74-88岁),其中38例为新诊断晚期卵巢癌、4例为复发性卵巢癌,于2015年5月至2018年1月间接受肿瘤细胞减灭术。

主要发现

  • 术前eRFA显示的年龄相关损害包括:高痛苦水平71%、功能依赖59%、社交活动受限59%、抑郁57%、起立行走试验缓慢54%、卡氏功能状态评分(KPS)≤80为41%、社会支持差43%、多重用药35%、体重下降>10磅25%、跌倒史244%、认知损害13%。
  • 中位合并症数量为3;38例新诊断患者中26例(68%)为IIIC期、11例(29%)为IV期;16例(42%)接受初次减灭术,22例(58%)接受新辅助化疗后间隔减灭术。
  • 中位手术时间245.5分钟(范围95-621),中位住院时间6天(范围0-22),最佳减灭率97%,完全肉眼切除率63%。
  • 1例患者入住ICU,26%发生30天急诊就诊,10%再入院;任何并发症、轻微并发症、严重并发症发生率分别为58%、55%、8%。
  • 中位术后至化疗时间34.5天(范围19-66),中位随访15.7个月(范围3.7-38.0),12个月生存率93.3%,无180天死亡。

临床怎么用

  • 作者认为,对于晚期卵巢癌且衰弱的老年女性,在三级医疗中心通过术前和术后老年医学与外科共管可安全实施肿瘤细胞减灭术。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess fitness and outcomes in older women undergoing cytoreductive surgery for advanced ovarian cancer (OC). METHODS: A prospective study of OC patients referred to Geriatrics Clinic for preoperative evaluation. All completed the electronic Rapid Fitness Assessment (eRFA) and were followed by Geriatrics Service during inpatient postoperative course, co-managed by Surgical Service. Outcomes were 30-day Intensive Care Unit (ICU) admission, emergency room (ER) visit, readmission, mortality, adverse surgical events. Descriptive statistics were used. RESULTS: Forty-two women (median age 79, range 74-88), 38 with newly diagnosed advanced OC, 4 with recurrent OC, underwent cytoreductive surgery between 5/2015 and 1/2018. Preoperative age-related impairments per eRFA: high level of distress (71%), functional dependency (59%), limited social activity (59%), depression (57%), slow Time Up and Go (54%), Karnofsky Performance Score (KPS) ≤ 80 (41%), poor social support (43%), polypharmacy (35%), weight loss>10 lbs. (25%), fall history (244%), cognitive impairment (13%). Median number of comorbid conditions = 3. Among 38 newly diagnosed women, 26 (68%) had stage IIIC, 11 (29%) stage IV. Sixteen (42%) underwent primary debulking surgery, 22 (58%) neoadjuvant chemotherapy followed by interval debulking surgery. Median duration of surgery = 245.5 min (range 95-621); median hospital length of stay = 6 days (range 0-22). Optimal debulking rate = 97%, complete gross resection rate = 63%. One patient was admitted to ICU, 26% had 30-day ER visit, 10% were readmitted. Any complication, minor complication, major complication occurred in 58%, 55%, 8%, respectively. Median time from surgery to postoperative chemotherapy = 34.5 days (range 19-66). Median follow-up = 15.7 months (range 3.7-38.0), 12-month survival = 93.3%. There was no 180-day mortality. CONCLUSION: Cytoreductive surgery among older women with advanced OC and frailty can be performed safely in a tertiary care center with preoperative/postoperative geriatric and surgical co-management.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Filippova OT, Chi DS, Long Roche K, et al. Geriatric co-management leads to safely performed cytoreductive surgery in older women with advanced stage ovarian cancer treated at a tertiary care cancer center. Gynecol Oncol. 2019. PMID: 31078241. doi:10.1016/j.ygyno.2019.04.683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。